GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Instadose Pharma Corp (OTCPK:INSD) » Definitions » Asset Turnover

Instadose Pharma (Instadose Pharma) Asset Turnover : 0.00 (As of Feb. 2022)


View and export this data going back to 2019. Start your Free Trial

What is Instadose Pharma Asset Turnover?

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Instadose Pharma's Revenue for the three months ended in Feb. 2022 was $0.00 Mil. Instadose Pharma's Total Assets for the quarter that ended in Feb. 2022 was $36.14 Mil. Therefore, Instadose Pharma's Asset Turnover for the quarter that ended in Feb. 2022 was 0.00.

Asset Turnover is linked to ROE % through Du Pont Formula. Instadose Pharma's annualized ROE % for the quarter that ended in Feb. 2022 was -25.99%. It is also linked to ROA % through Du Pont Formula. Instadose Pharma's annualized ROA % for the quarter that ended in Feb. 2022 was -10.03%.


Instadose Pharma Asset Turnover Historical Data

The historical data trend for Instadose Pharma's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Instadose Pharma Asset Turnover Chart

Instadose Pharma Annual Data
Trend Nov16 Nov17 Nov18 Nov19 Nov20 Nov21
Asset Turnover
Get a 7-Day Free Trial - 3.00 - - -

Instadose Pharma Quarterly Data
May17 Aug17 Nov17 Feb18 May18 Aug18 Nov18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22
Asset Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Instadose Pharma's Asset Turnover

For the Drug Manufacturers - Specialty & Generic subindustry, Instadose Pharma's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Instadose Pharma's Asset Turnover Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Instadose Pharma's Asset Turnover distribution charts can be found below:

* The bar in red indicates where Instadose Pharma's Asset Turnover falls into.



Instadose Pharma Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Instadose Pharma's Asset Turnover for the fiscal year that ended in Nov. 2021 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Nov. 2021 )/( (Total Assets (A: Nov. 2020 )+Total Assets (A: Nov. 2021 ))/ count )
=/( (0+0)/ 1 )
=/0
=

Instadose Pharma's Asset Turnover for the quarter that ended in Feb. 2022 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Feb. 2022 )/( (Total Assets (Q: Nov. 2021 )+Total Assets (Q: Feb. 2022 ))/ count )
=0/( (0+36.142)/ 1 )
=0/36.142
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.


Instadose Pharma  (OTCPK:INSD) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Instadose Pharma's annulized ROE % for the quarter that ended in Feb. 2022 is

ROE %**(Q: Feb. 2022 )
=Net Income/Total Stockholders Equity
=-3.624/13.944
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-3.624 / 0)*(0 / 36.142)*(36.142/ 13.944)
=Net Margin %*Asset Turnover*Equity Multiplier
= %*0*2.5919
=ROA %*Equity Multiplier
=-10.03 %*2.5919
=-25.99 %

Note: The Net Income data used here is four times the quarterly (Feb. 2022) net income data. The Revenue data used here is four times the quarterly (Feb. 2022) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Instadose Pharma's annulized ROA % for the quarter that ended in Feb. 2022 is

ROA %(Q: Feb. 2022 )
=Net Income/Total Assets
=-3.624/36.142
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-3.624 / 0)*(0 / 36.142)
=Net Margin %*Asset Turnover
= %*0
=-10.03 %

Note: The Net Income data used here is four times the quarterly (Feb. 2022) net income data. The Revenue data used here is four times the quarterly (Feb. 2022) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


Instadose Pharma Asset Turnover Related Terms

Thank you for viewing the detailed overview of Instadose Pharma's Asset Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Instadose Pharma (Instadose Pharma) Business Description

Traded in Other Exchanges
N/A
Address
5500 North Service Road, Suite 301, Burlington, ON, CAN, L7L 6W6
Instadose Pharma Corp, formerly Mikrocoze Inc is seeking to create a global distribution platform for medicinal cannabis and cannabinoid oil. The company endeavors to utilize the Global Distribution Platform to open the commercial gateway to a new wholesale marketplace along with providing pharmaceutical industry companies with large, sustainable, consistent, diverse, and low?cost supplies of high?quality medicinal cannabis and cannabinoid oil for use in bulk as an active pharmaceutical ingredient.

Instadose Pharma (Instadose Pharma) Headlines

From GuruFocus